Clarity Medical Group Holding Limited provided earnings guidance for the six months ended 30 September 2023. For the period, the Company is expected to record a net loss of not more than HKD 24.0 million for the six months ended 30 September 2023 as compared to a net profit of approximately HKD 7.9 million recorded for the six months ended 30 September 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 HKD | -1.89% | -3.70% | -17.46% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.46% | 35.87M | |
-18.52% | 16.2B | |
+5.41% | 12.73B | |
+3.98% | 11.68B | |
+4.36% | 10.22B | |
+28.07% | 8.6B | |
-4.98% | 7.78B | |
+6.76% | 6.73B | |
+7.33% | 6.4B | |
+48.17% | 4.49B |
- Stock Market
- Equities
- 1406 Stock
- News Clarity Medical Group Holding Limited
- Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023